The poster we presented at the Alzheimer’s Association International Conference is now available on the ETAP-Lab website; it’s all about our innovative in vitro and in vivo models of Alzheimer’s disease, which are based on the use of human A-Beta 1-42 oligomers.
The poster focuses on the main results of the characterisation of the model in the aged mouse. This reproducible and translational model is a new tool for the evaluation of compounds targeting the early stages of Alzheimer’s disease.
We are very pleased to be sharing this poster.
If you have any questions about our results, we’d be delighted to discuss them with you.
This research was carried out as part of the Bioprolor2 programme. Bioprolor2 is co-financed by the “Region Grand-Est” and the European Union through the “FEDER-FSE Lorraine et Massif des Vosges 2014-2020” operational programme.
